Lorenz R Rhomberg researcher (ORCID 0000-0002-0765-626X)
Rhomberg, Lorenz
VIAF ID: 56449712 ( Personal )
Permalink: http://viaf.org/viaf/56449712
Preferred Forms
-
100 0 _ ‡a Lorenz R Rhomberg ‡c researcher (ORCID 0000-0002-0765-626X)
-
100 1 _ ‡a Rhomberg, Lorenz
-
-
100 1 _ ‡a Rhomberg, Lorenz
-
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
The a posteriori probability of a kidney cancer cluster attributed to trichloroethylene exposure |
![]() |
Absolute risk or relative risk? A study of intraspecies and interspecies extrapolation of chemical-induced cancer risk |
![]() |
Advancements in Life Cycle Human Exposure and Toxicity Characterization |
![]() |
Analytical framework for assessing risks |
![]() |
Assessing human health response in life cycle assessment using ED10s and DALYs: part 2--Noncancer effects. |
![]() |
Causes of Life History Differences between the Morphs of Pemphigus populitransversus |
![]() |
CERHR conclusions would have been strengthened by a more explicit weight-of-evidence analysis. |
![]() |
Comment on "Chronic disease and early exposure to air-borne mixtures. 2. Exposure assessment" |
![]() |
Comment on "Residential and biological exposure assessment of chemicals from a wood treatment plant" by James Dahlgren et al. [Chemosphere 67(9) (2007) S279-S285] |
![]() |
A comprehensive evaluation of the potential health risks associated with occupational and environmental exposure to styrene |
![]() |
Contrasting directions and directives on hazard identification for formaldehyde carcinogenicity |
![]() |
Critical comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals - 2012. |
![]() |
A critique of the European Commission document, "State of the Art Assessment of Endocrine Disrupters". |
![]() |
Effects of MTBE on the reported incidence of Leydig cell tumors in Sprague-Dawley rats: range of possible Poly-3 results. |
![]() |
Evaluation of Acute Nonlymphocytic Leukemia and Its Subtypes With Updated Benzene Exposure and Mortality Estimates: A Lifetable Analysis of the Pliofilm Cohort. |
![]() |
Evaluation of the causal framework used for setting national ambient air quality standards. |
![]() |
Hypothesis-based weight-of-evidence evaluation of the human carcinogenicity of toluene diisocyanate. |
![]() |
Improving weight of evidence approaches to chemical evaluations |
![]() |
Incorporating Low-dose Epidemiology Data in a Chlorpyrifos Risk Assessment |
![]() |
Incorporating ToxCast™ data into naphthalene human health risk assessment |
![]() |
Is exposure to formaldehyde in air causally associated with leukemia?--A hypothesis-based weight-of-evidence analysis |
![]() |
Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection. |
![]() |
Letter to the editor re: Guyton et al. (2018), 'Application of the key characteristics of carcinogens in cancer hazard identification' |
![]() |
Linear low-dose extrapolation for noncancer responses is not generally appropriate. |
![]() |
Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: has the case been made? |
![]() |
A margin-of-exposure approach to assessment of noncancer risks of dioxins based on human exposure and response data |
![]() |
Measurement error in environmental epidemiology and the shape of exposure-response curves. |
![]() |
Mechanisms of action for arsenic in cardiovascular toxicity and implications for risk assessment. |
![]() |
Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study. |
![]() |
THE NATURE OF GENETIC VARIATION FOR SPECIES FORMATION |
![]() |
Practical Risk Assessment and Management Issues Arising were we to Adopt Low-Dose Linearity for all Endpoints |
![]() |
Quantitative assessment of lung and bladder cancer risk and oral exposure to inorganic arsenic: Meta-regression analyses of epidemiological data |
![]() |
Quantitative cancer risk assessment for occupational exposures to asphalt fumes during built-up roofing asphalt (BURA) operations. |
![]() |
Recommendations for the conduct of systematic reviews in toxicology and environmental health research (COSTER) |
![]() |
Seeking optimal design for animal bioassay studies |
![]() |
Strategies to protect the health of deployed U.S. forces, c2000: |
![]() ![]() ![]() ![]() |
Strengthening the foundation of next generation risk assessment. |
![]() |
A survey of frameworks for best practices in weight-of-evidence analyses. |
![]() |
Systematic comparison of study quality criteria. |
![]() |
Toxicity testing in the 21st century: how will it affect risk assessment? |
![]() |
Toxicological evaluation of carcinogenicity of the pyrethroid imiprothrin in rats and mice |
![]() |
Uncertainty factor conundrums: what lessons should we draw? |
![]() |
Weighing evidence and assessing uncertainties |
![]() |
Weight-of-evidence analysis of human exposures to dioxins and dioxin-like compounds and associations with thyroid hormone levels during early development. |
![]() |
The Weight of Evidence Does Not Support the Listing of Styrene as "Reasonably Anticipated to be a Human Carcinogen" in NTP's Twelfth Report on Carcinogens |
![]() |
Weight-of-evidence evaluation of reproductive and developmental effects of low doses of bisphenol A. |
![]() |